aap Implantate AG

Equities

AAQ1

DE000A3H2101

Medical Equipment, Supplies & Distribution

Market Closed - Xetra Other stock markets 11:36:15 2024-04-26 am EDT			5-day change	1st Jan Change
0.92 ^EUR	0.00%		+15.00%	+10.84%

2021	Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	CI
2021	Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	CI

Aap Implantate AG Revises Earnings Guidance for the Financial Year 2019

August 13, 2019 at 03:09 pm EDT

aap Implantate AG revised earnings guidance for the financial year 2019. The company adjusts its outlook for the financial year 2019 and now expects sales between EUR 11.0 million and EUR 13.0 million against previous forecast of EUR 13 million to EUR 15 million.

Latest news about aap Implantate AG

Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	21-07-27	CI
Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Aap Implantate AG Provides Earnings Guidance for the Year 2021	21-04-30	CI
Aap Implantate AG Announces Sales Results for the First Quarter of 2021	21-04-26	CI
Aap Implantate AG Provides Sales Guidance for the Second Quarter of 2021	21-04-26	CI
Aap Implantate AG Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2020	21-01-21	CI
Aap Implantate AG Provides Earnings Guidance for the Fiscal Year 2021	21-01-21	CI
Aap Implantate AG Appoints Agnieszka Mierzejewska as COO with Effect from 1 January 2021	20-12-18	CI
Aap Implantate AG Provides Earnings Guidance for the Year 2020	20-10-26	CI
Aap Implantate AG Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2020	20-10-09	CI
Aap Implantate AG Provides Earnings Guidance for the Full Year of Fiscal 2020	20-08-14	CI
Aap Implantate AG Provides Earnings Guidance for 2020	20-06-30	CI
Aap Receives Approval from Ethics Commissions for Human Clinical Study for Innovative Antibacterial Silver Coating Technology; All Regulatory Requirements for Starting Study in Germany Fulfilled	20-04-23	CI
Aap Implantate AG Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2019	20-01-28	CI
Aap Implantate AG Receives Further Funding of Up to Eur 2.7 Million for Its Innovative Antibacterial Silver Coating Technology	19-11-19	CI
Aap Implantate AG Provides Revenue Guidance for the Year 2019	19-11-14	CI
Aap Implantate AG Receives US-American Clearance for Polyaxial LOQTEQ(R) VA Calcaneus System	19-08-21	CI
Aap Implantate Ag Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Aap Implantate AG Revises Earnings Guidance for the Financial Year 2019	19-08-13	CI
Aap Implantate AG Receives BfArM Approval for Human Clinical Study and Becomes Global Bellwether in Antibacterial Coating for Trauma Implants	19-08-08	CI
Aap Implantate AG Is Granted European Patent for Its Innovative Resorbable Magnesium Implant Technology	19-07-22	CI
Aap Implantate Receives US-American Approval for Polyaxial Loqteq(R) VA Foot System	19-07-12	CI
Aap Implantate AG Appoints Med. Nathalie Krebs as New Supervisory Board Chairwoman	19-07-04	CI
Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-30	CI
Aap Implantate AG Provides Earnings Guidance for 2019	19-04-30	CI

Chart aap Implantate AG

Duration

Period

More charts

Company Profile

aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for aap Implantate AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.92 EUR

Average target price

0.8 EUR

Spread / Average Target

-13.04%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AAP IMPLANTATE AG	+10.84%	9.68M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution